Anti-endothelial cell antibodies (AECA) in patients with systemic vasculitis: our research using proteomics

Bibliography

• Khasnis A, Langford CA. Update on vasculitis. J Allergy Clin Immunol 2009;123:1226-36
   PubMed Web of Science ®Google Scholar
• Sneller MC, Fauci AS. Pathogenesis of vasculitis syndromes. Med Clin North Am 1997;81:221-42
   PubMed Web of Science ®Google Scholar
• Kallenberg CG. Autoantibodies in vasculitis: current perspectives. Clin Exp Rheumatol 1993;11:355-60
   PubMed Web of Science ®Google Scholar
• Kallenberg CG. Pathogenesis of PR3-ANCA associated vasculitis. J Autoimmun 2008;30:29-36
   PubMed Web of Science ®Google Scholar
• Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988;318:1651-7
   PubMed Web of Science ®Google Scholar
• Terrier B, Saadoun D, Sene D, Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides. Ann Rheum Dis 2009;68:1564-71
   PubMed Web of Science ®Google Scholar
• Holmen C, Christensson M, Pettersson E, Wegener's granulomatosis is associated with organ-specific antiendothelial cell antibodies. Kidney Int 2004;66:1049-60
   PubMed Web of Science ®Google Scholar
• Muller Kobold AC, van Wijk RT, Franssen CF, In vitro up-regulation of E-selectin and induction of interleukin-6 in endothelial cells by autoantibodies in Wegener's granulomatosis and microscopic polyangiitis. Clin Exp Rheumatol 1999;17:433-40
   PubMed Web of Science ®Google Scholar
• Grunebaum E, Blank M, Cohen S, The role of anti-endothelial cell antibodies in Kawasaki disease – in vitro and in vivo studies. Clin Exp Immunol 2002;130:233-40
   PubMed Web of Science ®Google Scholar
• Zeng XJ, Zhu WG, Deng XX, Anti-endothelial cell antibodies in systemic vasculitis: detection and correlation with disease activity. Zhonghua Yi Xue Za Zhi 2004;84:1629-32
   PubMedGoogle Scholar
• Navarro M, Cervera R, Font J, Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance. Lupus 1997;6:521-6
   PubMed Web of Science ®Google Scholar
• Dieude M, Senecal JL, Raymond Y. Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial cell autoantibody-positive systemic lupus erythematosus patients. Arthritis Rheum 2004;50:3221-31
   PubMed Web of Science ®Google Scholar
• Aydìntug AO, Tokgoz G, D'Cruz DP, Antibodies to endothelial cells in patients with Behçet's disease. Clin Immunol Immunopathol 1993;67:157-62
   PubMedGoogle Scholar
• Souza RC, Lage L, Goldenstein-Schainberg C, Anti-endothelial cell antibodies and central nervous system involvement in Behcet's disease. Clinics (Sao Paulo) 2007;62:685-90
   PubMed Web of Science ®Google Scholar
• Lindqvist KJ, Osterland CK. Human antibodies to vascular endothelium. Clin Exp Immunol 1971;9:753-60
   PubMed Web of Science ®Google Scholar
• Tan EM, Pearson CM. Rheumatic disease sera reactive with capillaries in the mouse kidney. Arthritis Rheum 1972;15:23-8
   PubMed Web of Science ®Google Scholar
• Westphal JR, Boerbooms AM, Schalwijk CJ, Anti-endothelial cell antibodies in sera of patients with autoimmune diseases: comparison between ELISA and FACS analysis. Clin Exp Immunol 1994;96:444-9
   PubMed Web of Science ®Google Scholar
• Revelen R, D'Arbonneau F, Guillevin L, Comparison of cell-ELISA, flow cytometry and Western blotting for the detection of antiendothelial cell antibodies. Clin Exp Rheumatol 2002;20:19-26
   PubMed Web of Science ®Google Scholar
• Vismara A, Meroni PL, Tincani A, Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol 1988;74:247-53
   PubMed Web of Science ®Google Scholar
• Heurkens AH, Hiemstra PS, Lafeber GJ, Anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by vasculitis. Clin Exp Immunol 1989;78:7-12
   PubMed Web of Science ®Google Scholar
• Wusirika R, Ferri C, Marin M, The assessment of anti-endothelial cell antibodies in scleroderma-associated pulmonary fibrosis. A study of indirect immunofluorescent and western blot analysis in 49 patients with scleroderma. Am J Clin Pathol 2003;120:596-606
   PubMed Web of Science ®Google Scholar
• Del Papa N, Conforti G, Gambini D, Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis. Clin Immunol Immunopathol 1994;70:211-16
   PubMedGoogle Scholar
• Rosenbaum J, Pottinger BE, Woo P, Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol 1988;72:450-6
   PubMed Web of Science ®Google Scholar
• Wangel AG, Kontiainen S, Scheinin T, Anti-endothelial cell antibodies in insulin-dependent diabetes mellitus. Clin Exp Immunol 1992;88:410-13
   PubMed Web of Science ®Google Scholar
• Youinou P. New target antigens for anti-endothelial cell antibodies. Immunobiology 2005;210:789-97
   PubMed Web of Science ®Google Scholar
• Park MC, Park YB, Jung SY, Anti-endothelial cell antibodies and antiphospholipid antibodies in Takayasu's arteritis: correlations of their titers and isotype distributions with disease activity. Clin Exp Rheumatol 2006;24:S10-16
   PubMed Web of Science ®Google Scholar
• Sebastian JK, Mahr AD, Ahmed SS, Antiendothelial cell antibodies in patients with Wegener's granulomatosis: prevalence and correlation with disease activity and manifestations. J Rheumatol 2007;34:1027-31
   PubMed Web of Science ®Google Scholar
• Kaneko K, Savage CO, Pottinger BE, Antiendothelial cell antibodies can be cytotoxic to endothelial cells without cytokine pre-stimulation and correlate with ELISA antibody measurement in Kawasaki disease. Clin Exp Immunol 1994;98:264-9
   PubMed Web of Science ®Google Scholar
• Fujieda M, Oishi N, Kurashige T. Antibodies to endothelial cells in Kawasaki disease lyse endothelial cells without cytokine pretreatment. Clin Exp Immunol 1997;107:120-6
   PubMed Web of Science ®Google Scholar
• Holt CM, Lindsey N, Moult J, Antibody-dependent cellular cytotoxicity of vascular endothelium: characterization and pathogenic associations in systemic sclerosis. Clin Exp Immunol 1989;78:359-65
   PubMed Web of Science ®Google Scholar
• Praprotnik S, Blank M, Meroni PL, Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications. Arthritis Rheum 2001;44:1484-94
   PubMed Web of Science ®Google Scholar
• Mihai C, Tervaert JW. Anti-endothelial cell antibodies in systemic sclerosis. Ann Rheum Dis 2010;69:319-24
   PubMed Web of Science ®Google Scholar
• Del Papa N, Conforti G, Gambini D, Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis. Clin Immunol Immunopathol 1994;70:211-16
   PubMedGoogle Scholar
• Chan TM, Frampton G, Staines NA, Different mechanisms by which anti-DNA MoAbs bind to human endothelial cells and glomerular mesangial cells. Clin Exp Immunol 1992;88:68-74
   PubMed Web of Science ®Google Scholar
• Mayet WJ, Csernok E, Szymkowiak C, Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis. Blood 1993;82:1221-9
   PubMed Web of Science ®Google Scholar
• Del Papa N, Sheng YH, Raschi E, Human beta2-glycoprotein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti-beta2-glycoprotein I antibodies. J Immunol 1998;160:5572-8
   PubMed Web of Science ®Google Scholar
• Yang YH, Wang SJ, Chuang YH, The level of IgA antibodies to human umbilical vein endothelial cells can be enhanced by TNF-alpha treatment in children with Henoch-Schönlein purpura. Clin Exp Immunol 2002;130:352-7
   PubMed Web of Science ®Google Scholar
• Tripathy NK, Upadhyaya S, Sinha N, Complement and cell mediated cytotoxicity by antiendothelial cell antibodies in Takayasu's arteritis. J Rheumatol 2001;28:805-8
   PubMed Web of Science ®Google Scholar
• Marks RM, Czerniecki M, Andrews BS, The effects of scleroderma serum on human microvascular endothelial cells. Induction of antibody-dependent cellular cytotoxicity. Arthritis Rheum 1988;31:1524-34
   PubMed Web of Science ®Google Scholar
• Jamin C, Dugue C, Alard JE, Induction of endothelial cell apoptosis by the binding of anti-endothelial cell antibodies to Hsp60 in vasculitis-associated systemic autoimmune diseases. Arthritis Rheum 2005;52:4028-38
   PubMed Web of Science ®Google Scholar
• Schett G, Xu Q, Amberger A, Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest 1995;96:2569-77
   PubMed Web of Science ®Google Scholar
• Bordron A, Dueymes M, Levy Y, The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. J Clin Invest 1998;101:2029-35
   PubMed Web of Science ®Google Scholar
• Sgonc R, Gruschwitz MS, Boeck G, Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95. Arthritis Rheum 2000;43:2550-62
   PubMed Web of Science ®Google Scholar
• Williams JM, Colman R, Brookes CJ, Anti-endothelial cell antibodies from lupus patients bind to apoptotic endothelial cells promoting macrophage phagocytosis but do not induce apoptosis. Rheumatology (Oxford) 2005;44:879-84
   PubMed Web of Science ®Google Scholar
• Mukae H, Matsumoto N, Ashitani J, Neutrophil-related cytokines and neutrophil products in bronchoalveolar lavage fluid of a patient with ANCA negative Wegener's granulomatosis. Eur Respir J 1996;9:1950-4
   PubMed Web of Science ®Google Scholar
• Kaneko F, Oyama N, Yanagihori H, The role of streptococcal hypersensitivity in the pathogenesis of Behcet's Disease. Eur J Dermatol 2008;18:489-98
   PubMed Web of Science ®Google Scholar
• Ohlsson S, Bakoush O, Tencer J, Monocyte chemoattractant protein 1 is a prognostic marker in ANCA-associated small vessel vasculitis. Mediators Inflamm 2009; 2009:584916: published online 11 May 2009, doi:10.1155/2009/584916
   Google Scholar
• Chung HS, Kim HY, Kim HS, Production of chemokines in Kawasaki disease, Henoch-Schonlein purpura and acute febrile illness. J Korean Med Sci 2004;19:800-4
   PubMed Web of Science ®Google Scholar
• Baggiolini M, Walz A, Kunkel SL. Neutrophil activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989;84:1045-9
   PubMed Web of Science ®Google Scholar
• Blank M, Krause I, Goldkorn T, Monoclonal anti-endothelial cell antibodies from a patient with Takayasu arteritis activate endothelial cells from large vessels. Arthritis Rheum 1999;42:1421-32
   PubMed Web of Science ®Google Scholar
• Chauhan SK, Tripathy NK, Nityanand S. Antigenic targets and pathogenicity of anti-aortic endothelial cell antibodies in Takayasu arteritis. Arthritis Rheum 2006;54:2326-33
   PubMed Web of Science ®Google Scholar
• Williams N, De Giorgio T, Banu N, Recombinant interleukin 6 stimulates immature murine megakaryocytes. Exp Hematol 1990;18:69-72
   PubMed Web of Science ®Google Scholar
• Noris M, Daina E, Gamba S, Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions? Circulation 1999;100:55-60
   PubMed Web of Science ®Google Scholar
• Breland UM, Halvorsen B, Hol J, A potential role of the CXC chemokine GROalpha in atherosclerosis and plaque destabilization. downregulatory effects of statins. Arterioscler Thromb Vasc Biol 2008;28:1005-11
   PubMed Web of Science ®Google Scholar
• Takahashi T, Hato F, Yamane T, Activation of human neutrophil by cytokine-activated endothelial cells. Circ Res 2001;88:422-9
   PubMed Web of Science ®Google Scholar
• Carvalho D, Savage CO, Isenberg D, IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner. Arthritis Rheum 1999;42:631-40
   PubMed Web of Science ®Google Scholar
• Carvalho D, Savage CO, Black CM, IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines. J Clin Invest 1996;97:111-19
   PubMed Web of Science ®Google Scholar
• Levi M, van der Poll T, ten Cate H, The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. Eur J Clin Invest 1997;27:3-9
   PubMed Web of Science ®Google Scholar
• Yong K, Cohen H, Khwaja A, Lack of effect of granulocyte-macrophage and granulocyte colony-stimulating factors on cultured human endothelial cells. Blood 1991;77:1675-80
   PubMed Web of Science ®Google Scholar
• Tannenbaum SH, Finko R, Cines DB. Antibody and immune complexes induce tissue factor production by human endothelial cells. J Immunol 1986;137:1532-7
   PubMed Web of Science ®Google Scholar
• Renaudineau Y, Dugue C, Dueymes M, Antiendothelial cell antibodies in systemic lupus erythematosus. Autoimmun Rev 2002;1:365-72
   PubMedGoogle Scholar
• Lee KH, Chung HS, Kim HS, Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behcet's disease. Arthritis Rheum 2003;48:2025-35
   PubMed Web of Science ®Google Scholar
• Kaneko M, Ono T, Matsubara T, Serological identification of endothelial antigens predominantly recognized in Kawasaki disease patients by recombinant expression cloning. Microbiol Immunol 2004;48:703-11
   PubMed Web of Science ®Google Scholar
• Garcia de la Pena-Lefebvre P, Chanseaud Y, Tamby MC, IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patients. Clin Immunol 2004;111:241-51
   PubMed Web of Science ®Google Scholar
• Servettaz A, Tamby MC, Guilpain P, Anti-endothelial cell antibodies from patients with limited cutaneous systemic sclerosis bind to centromeric protein B (CENP-B). Clin Immunol 2006;120:212-19
   PubMed Web of Science ®Google Scholar
• Karasawa R, Kurokawa MS, Yudoh K, Peroxiredoxin 2 is a novel autoantigen for anti-endothelial cell antibodies in systemic vasculitis. Clin Exp Immunol 2010;161:459-70
   PubMed Web of Science ®Google Scholar
• Damianovich M, Gilburd B, George J, Pathogenic role of anti-endothelial cell antibodies in vasculitis. An idiotypic experimental model. J Immunol 1996;156:4946-51
   PubMed Web of Science ®Google Scholar
• Choi MH, Lee IK, Kim GW, Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature 2005;435:347-53
   PubMed Web of Science ®Google Scholar
• Nishimoto N, Nakahara H, Yoshio-Hoshino N, Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody. Arthritis Rheum 2008;58:1197-200
   PubMed Web of Science ®Google Scholar
• Margutti P, Matarrese P, Conti F, Autoantibodies to the C-terminal subunit of RLIP76 induce oxidativestress and endothelial cell apoptosis in immune-mediated vascular diseases and atherosclerosis. Blood 2008;111:4559-70
   PubMed Web of Science ®Google Scholar
• Ortona E, Margutti P, Matarrese P, Redox state, cell death and autoimmune diseases: a gender perspective. Autoimmun Rev 2008;7:579-84
   PubMed Web of Science ®Google Scholar